Durando, Paolo <br/><br/>
The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.  [electronic resource] 

 -  Vaccine  08 2016 
 - 4278-84 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2016.07.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Viral--blood<br/>Chickenpox Vaccine--administration & dosage<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Fever<br/>Healthy Volunteers<br/>Herpesvirus 3, Human--immunology<br/>Humans<br/>Immunization Schedule<br/>Immunogenicity, Vaccine<br/>Infant<br/>Italy<br/>Male<br/>Measles virus--immunology<br/>Measles-Mumps-Rubella Vaccine--administration & dosage<br/>Meningococcal Infections--prevention & control<br/>Meningococcal Vaccines--administration & dosage<br/>Mumps virus--immunology<br/>Rubella virus--immunology<br/>Seroconversion<br/>Vaccines, Combined--administration & dosage